Annual Total Debt
$2.75 B
-$94.61 M-3.33%
31 December 2023
Summary:
Amneal Pharmaceuticals annual total debt is currently $2.75 billion, with the most recent change of -$94.61 million (-3.33%) on 31 December 2023. During the last 3 years, it has fallen by -$194.40 million (-6.60%). AMRX annual total debt is now -6.60% below its all-time high of $2.94 billion, reached on 31 December 2020.AMRX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$2.64 B
-$80.48 M-2.95%
30 September 2024
Summary:
Amneal Pharmaceuticals quarterly total debt is currently $2.64 billion, with the most recent change of -$80.48 million (-2.95%) on 30 September 2024. Over the past year, it has dropped by -$160.03 million (-5.71%). AMRX quarterly total debt is now -19.36% below its all-time high of $3.28 billion, reached on 31 March 2020.AMRX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX Total Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -3.3% | -5.7% |
3 y3 years | -6.6% | -8.3% |
5 y5 years | +2.2% | -4.6% |
AMRX Total Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -6.6% | at low | -8.8% | at low |
5 y | 5 years | -6.6% | +2.2% | -19.4% | at low |
alltime | all time | -6.6% | -19.4% |
Amneal Pharmaceuticals Total Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $2.64 B(-3.0%) |
June 2024 | - | $2.73 B(-0.8%) |
Mar 2024 | - | $2.75 B(-0.2%) |
Dec 2023 | $2.75 B(-3.3%) | $2.75 B(-1.9%) |
Sept 2023 | - | $2.80 B(-1.9%) |
June 2023 | - | $2.86 B(+0.2%) |
Mar 2023 | - | $2.85 B(+0.3%) |
Dec 2022 | $2.85 B(-1.1%) | $2.85 B(-0.4%) |
Sept 2022 | - | $2.86 B(-1.4%) |
June 2022 | - | $2.90 B(+1.1%) |
Mar 2022 | - | $2.87 B(-0.3%) |
Dec 2021 | $2.88 B(-2.3%) | $2.88 B(-0.3%) |
Sept 2021 | - | $2.88 B(-1.2%) |
June 2021 | - | $2.92 B(-0.1%) |
Mar 2021 | - | $2.92 B(-0.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2020 | $2.94 B(+6.3%) | $2.94 B(-0.6%) |
Sept 2020 | - | $2.96 B(-0.4%) |
June 2020 | - | $2.97 B(-9.3%) |
Mar 2020 | - | $3.28 B(+18.4%) |
Dec 2019 | $2.77 B(+2.9%) | $2.77 B(-0.1%) |
Sept 2019 | - | $2.77 B(-0.3%) |
June 2019 | - | $2.78 B(-0.3%) |
Mar 2019 | - | $2.79 B(+3.7%) |
Dec 2018 | $2.69 B(+81.3%) | $2.69 B(-6.4%) |
Sept 2018 | - | $2.87 B(+3.4%) |
June 2018 | - | $2.78 B(>+9900.0%) |
Mar 2018 | - | $0.00(-100.0%) |
Dec 2017 | $1.48 B(>+9900.0%) | $1.48 B(>+9900.0%) |
Sept 2017 | - | $0.00(0.0%) |
June 2017 | - | $0.00 |
Dec 2016 | $0.00 | - |
FAQ
- What is Amneal Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual total debt year-on-year change?
- What is Amneal Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly total debt year-on-year change?
What is Amneal Pharmaceuticals annual total debt?
The current annual total debt of AMRX is $2.75 B
What is the all time high annual total debt for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual total debt is $2.94 B
What is Amneal Pharmaceuticals annual total debt year-on-year change?
Over the past year, AMRX annual total debt has changed by -$94.61 M (-3.33%)
What is Amneal Pharmaceuticals quarterly total debt?
The current quarterly total debt of AMRX is $2.64 B
What is the all time high quarterly total debt for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly total debt is $3.28 B
What is Amneal Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, AMRX quarterly total debt has changed by -$160.03 M (-5.71%)